United States Biotechnology & Medical Research

Skye Bioscience, Inc. (SKYE)

Skye Bioscience experienced significant selling activity over the past ninety days, totaling approximately $889,203 in divestments. Key stakeholders, specifically 5AM Partners VII and Andrew J. Schwab, executed thirty transactions. These outflows occurred despite an 85.7% stock price increase, preceding the next scheduled results financiers release in November 2026.
Ticker: SKYE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Skye Bioscience, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
365.73
Quantity 79,271 +17.3%
Value US$1,678,634
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
52.65
Quantity 73,473 -26.4%
Value US$4,849,902
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
390.78
Quantity 99,854 +48.4%
Value US$998,252
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
1.61
Quantity 114,851 -100.0%
Value US$184,910
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
1.65
Quantity 1,088 -19.4%
Value US$1,795
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
1.65
Quantity 27,612 -19.4%
Value US$45,560
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
1.65
Quantity 1,088 -19.4%
Value US$1,795
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
1.65
Quantity 27,612 -19.4%
Value US$45,560
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
1.91
Quantity 1,285 -18.6%
Value US$2,454
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
1.91
Quantity 32,607 -18.6%
Value US$62,279
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
1.91
Quantity 1,285 -18.6%
Value US$2,454
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
1.91
Quantity 32,607 -18.6%
Value US$62,279
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.32
Quantity 6,495 -0.1%
Value US$2,078
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.32
Quantity 46 -0.1%
Value US$15
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.32
Quantity 1,159 -0.1%
Value US$371
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
0.32
Quantity 6,495 -0.1%
Value US$2,078
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.35
Quantity 57,476 -0.7%
Value US$20,117
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.35
Quantity 409 -0.7%
Value US$143
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.35
Quantity 10,255 -0.7%
Value US$3,589
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
0.35
Quantity 57,476 -0.7%
Value US$20,117
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
0.35
Quantity 10,255 -0.7%
Value US$3,589
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.38
Quantity 253,080 -3.1%
Value US$96,170
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.38
Quantity 1,830 -3.2%
Value US$695
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.38
Quantity 45,090 -3.1%
Value US$17,134
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
0.38
Quantity 253,080 -3.1%
Value US$96,170
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
0.38
Quantity 45,090 -3.1%
Value US$17,134
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
3.42
Quantity 6,470 -10.1%
Value US$22,127
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
3.42
Quantity 163,979 -10.1%
Value US$560,808
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.42
Quantity 6,470 -10.1%
Value US$22,127
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.42
Quantity 163,979 -10.1%
Value US$560,808
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
3.57
Quantity 2,314 -3.5%
Value US$8,261
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
3.57
Quantity 58,642 -3.5%
Value US$209,352
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.57
Quantity 2,314 -3.5%
Value US$8,261
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.57
Quantity 58,642 -3.5%
Value US$209,352
Diep Tuan Tu Chief Development Officer Officer
Transaction date
Sale
Price
4.99
Quantity 19,489 -19.2%
Value US$97,250
ARSENAULT KAITLYN Chief Financial Officer Officer
Transaction date
Sale
Price
4.99
Quantity 43,206 -20.6%
Value US$215,598
DHILLON PUNIT Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.99
Quantity 82,546 -20.0%
Value US$411,905
Grayson Paul A. Non-Executive Director
Transaction date
Sale
Price
4.99
Quantity 86,244 -24.9%
Value US$430,358
Diep Tuan Tu Chief Development Officer Officer
Transaction date
Sale
Price
5.55
Quantity 85 -0.1%
Value US$472
ARSENAULT KAITLYN Chief Financial Officer Officer
Transaction date
Sale
Price
5.55
Quantity 190 -0.1%
Value US$1,054
DHILLON PUNIT Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.55
Quantity 364 -0.1%
Value US$2,020
Grayson Paul A. Non-Executive Director
Transaction date
Sale
Price
5.55
Quantity 307 -0.1%
Value US$1,704
ARSENAULT KAITLYN Officer Officer
Transaction date
Proposed sale
Price
5.51
Quantity 57,084
Value US$314,533
DHILLON PUNIT Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.51
Quantity 100,693
Value US$554,818
Diep Tuan Tu Officer Officer
Transaction date
Proposed sale
Price
5.51
Quantity 22,877
Value US$126,052
Grayson Paul A. Director Non-Executive Director
Transaction date
Proposed sale
Price
5.51
Quantity 86,804
Value US$478,290
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.06
Quantity 79 -0.1%
Value US$479
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.06
Quantity 2,000 -0.1%
Value US$12,120
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.06
Quantity 11,758 -0.1%
Value US$71,253
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
6.06
Quantity 2,000 -0.1%
Value US$12,120
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
6.06
Quantity 11,758 -0.1%
Value US$71,253
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.60
Quantity 1,440 -2.1%
Value US$9,504
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.60
Quantity 36,504 -2.1%
Value US$240,926
1.5
Schwab Andrew J. Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.60
Quantity 214,556 -2.6%
Value US$1,416,070
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
6.60
Quantity 1,440 -2.1%
Value US$9,504
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
6.60
Quantity 36,504 -2.1%
Value US$240,926
5AM Partners VII, LLC Large shareholder
Transaction date
Sale
Price
6.60
Quantity 214,556 -2.6%
Value US$1,416,070
5AM Partners VII, LLC Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 450,000 +5.7%
Value US$4,500,000
5AM Partners VII, LLC Large shareholder
Transaction date
Purchase
Price
2.31
Quantity 5,206,074 +190.2%
Value US$12,026,031
DHILLON PUNIT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.02
Quantity 881,000 +2.2%
Value US$16,475
Emerald Health Sciences Inc. Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 15,000,000
Value US$0
Ladin Brian D Large shareholder
Transaction date
Sale
Price
4.93
Quantity 11,830 -4.5%
Value US$58,310
Ladin Brian D Large shareholder
Transaction date
Sale
Price
4.79
Quantity 15,800 -5.7%
Value US$75,682
Ladin Brian D Large shareholder
Transaction date
Sale
Price
4.69
Quantity 23,000 -7.7%
Value US$107,893
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-24 2026-09-23 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
79,271 +17.3%
365.73
US$1,678,634 		79,271 +17.3% 365.73 US$1,678,634
2026-09-24 2026-09-23 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
73,473 -26.4%
52.65
US$4,849,902 		73,473 -26.4% 52.65 US$4,849,902
2026-09-24 2026-09-23 S Sale
5AM Partners VII, LLC
Large shareholder
99,854 +48.4%
390.78
US$998,252 		99,854 +48.4% 390.78 US$998,252
2026-09-24 2026-09-23 S Sale
5AM Partners VII, LLC
Large shareholder
114,851 -100.0%
1.61
US$184,910 		114,851 -100.0% 1.61 US$184,910
2026-09-24 2026-09-22 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
1,088 -19.4%
1.65
US$1,795 		1,088 -19.4% 1.65 US$1,795
2026-09-24 2026-09-22 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
27,612 -19.4%
1.65
US$45,560 		27,612 -19.4% 1.65 US$45,560
2026-09-24 2026-09-22 S Sale
5AM Partners VII, LLC
Large shareholder
1,088 -19.4%
1.65
US$1,795 		1,088 -19.4% 1.65 US$1,795
2026-09-24 2026-09-22 S Sale
5AM Partners VII, LLC
Large shareholder
27,612 -19.4%
1.65
US$45,560 		27,612 -19.4% 1.65 US$45,560
2026-09-18 2026-09-16 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
1,285 -18.6%
1.91
US$2,454 		1,285 -18.6% 1.91 US$2,454
2026-09-18 2026-09-16 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
32,607 -18.6%
1.91
US$62,279 		32,607 -18.6% 1.91 US$62,279
2026-09-18 2026-09-16 S Sale
5AM Partners VII, LLC
Large shareholder
1,285 -18.6%
1.91
US$2,454 		1,285 -18.6% 1.91 US$2,454
2026-09-18 2026-09-16 S Sale
5AM Partners VII, LLC
Large shareholder
32,607 -18.6%
1.91
US$62,279 		32,607 -18.6% 1.91 US$62,279
2026-08-20 2026-08-20 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
6,495 -0.1%
0.32
US$2,078 		6,495 -0.1% 0.32 US$2,078
2026-08-20 2026-08-20 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
46 -0.1%
0.32
US$15 		46 -0.1% 0.32 US$15
2026-08-20 2026-08-20 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
1,159 -0.1%
0.32
US$371 		1,159 -0.1% 0.32 US$371
2026-08-20 2026-08-20 S Sale
5AM Partners VII, LLC
Large shareholder
6,495 -0.1%
0.32
US$2,078 		6,495 -0.1% 0.32 US$2,078
2026-08-20 2026-08-20 S Sale
5AM Partners VII, LLC
Large shareholder
46 -0.1%
0.32
US$15 		46 -0.1% 0.32 US$15
2026-08-20 2026-08-20 S Sale
5AM Partners VII, LLC
Large shareholder
1,159 -0.1%
0.32
US$371 		1,159 -0.1% 0.32 US$371
2026-08-20 2026-08-19 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
57,476 -0.7%
0.35
US$20,117 		57,476 -0.7% 0.35 US$20,117
2026-08-20 2026-08-19 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
409 -0.7%
0.35
US$143 		409 -0.7% 0.35 US$143
2026-08-20 2026-08-19 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
10,255 -0.7%
0.35
US$3,589 		10,255 -0.7% 0.35 US$3,589
2026-08-20 2026-08-19 S Sale
5AM Partners VII, LLC
Large shareholder
57,476 -0.7%
0.35
US$20,117 		57,476 -0.7% 0.35 US$20,117
2026-08-20 2026-08-19 S Sale
5AM Partners VII, LLC
Large shareholder
409 -0.7%
0.35
US$143 		409 -0.7% 0.35 US$143
2026-08-20 2026-08-19 S Sale
5AM Partners VII, LLC
Large shareholder
10,255 -0.7%
0.35
US$3,589 		10,255 -0.7% 0.35 US$3,589
2026-08-20 2026-08-18 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
253,080 -3.1%
0.38
US$96,170 		253,080 -3.1% 0.38 US$96,170
2026-08-20 2026-08-18 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
1,830 -3.2%
0.38
US$695 		1,830 -3.2% 0.38 US$695
2026-08-20 2026-08-18 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
45,090 -3.1%
0.38
US$17,134 		45,090 -3.1% 0.38 US$17,134
2026-08-20 2026-08-18 S Sale
5AM Partners VII, LLC
Large shareholder
253,080 -3.1%
0.38
US$96,170 		253,080 -3.1% 0.38 US$96,170
2026-08-20 2026-08-18 S Sale
5AM Partners VII, LLC
Large shareholder
1,830 -3.2%
0.38
US$695 		1,830 -3.2% 0.38 US$695
2026-08-20 2026-08-18 S Sale
5AM Partners VII, LLC
Large shareholder
45,090 -3.1%
0.38
US$17,134 		45,090 -3.1% 0.38 US$17,134
2025-08-22 2025-08-22 S Sale
5AM Partners VII, LLC
Large shareholder
6,470 -10.1%
3.42
US$22,127 		6,470 -10.1% 3.42 US$22,127
2025-08-22 2025-08-22 S Sale
5AM Partners VII, LLC
Large shareholder
163,979 -10.1%
3.42
US$560,808 		163,979 -10.1% 3.42 US$560,808
2025-08-22 2025-08-22 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
6,470 -10.1%
3.42
US$22,127 		6,470 -10.1% 3.42 US$22,127
2025-08-22 2025-08-22 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
163,979 -10.1%
3.42
US$560,808 		163,979 -10.1% 3.42 US$560,808
2025-08-22 2025-08-21 S Sale
5AM Partners VII, LLC
Large shareholder
2,314 -3.5%
3.57
US$8,261 		2,314 -3.5% 3.57 US$8,261
2025-08-22 2025-08-21 S Sale
5AM Partners VII, LLC
Large shareholder
58,642 -3.5%
3.57
US$209,352 		58,642 -3.5% 3.57 US$209,352
2025-08-22 2025-08-21 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
2,314 -3.5%
3.57
US$8,261 		2,314 -3.5% 3.57 US$8,261
2025-08-22 2025-08-21 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
58,642 -3.5%
3.57
US$209,352 		58,642 -3.5% 3.57 US$209,352
2024-11-20 2024-11-18 S Sale
Diep Tuan Tu

Chief Development Officer

Officer
19,489 -19.2%
4.99
US$97,250 		19,489 -19.2% 4.99 US$97,250
2024-11-19 2024-11-18 S Sale
ARSENAULT KAITLYN

Chief Financial Officer

Officer
43,206 -20.6%
4.99
US$215,598 		43,206 -20.6% 4.99 US$215,598
2024-11-19 2024-11-18 S Sale
DHILLON PUNIT

Chief Executive Officer

Executive Director
82,546 -20.0%
4.99
US$411,905 		82,546 -20.0% 4.99 US$411,905
2024-11-19 2024-11-18 S Sale
Grayson Paul A.
Non-Executive Director
86,244 -24.9%
4.99
US$430,358 		86,244 -24.9% 4.99 US$430,358
2024-11-20 2024-11-15 S Sale
Diep Tuan Tu

Chief Development Officer

Officer
85 -0.1%
5.55
US$472 		85 -0.1% 5.55 US$472
2024-11-19 2024-11-15 S Sale
ARSENAULT KAITLYN

Chief Financial Officer

Officer
190 -0.1%
5.55
US$1,054 		190 -0.1% 5.55 US$1,054
2024-11-19 2024-11-15 S Sale
DHILLON PUNIT

Chief Executive Officer

Executive Director
364 -0.1%
5.55
US$2,020 		364 -0.1% 5.55 US$2,020
2024-11-19 2024-11-15 S Sale
Grayson Paul A.
Non-Executive Director
307 -0.1%
5.55
US$1,704 		307 -0.1% 5.55 US$1,704
2024-11-15 2024-11-15 PrS Proposed sale
ARSENAULT KAITLYN

Officer

Officer
57,084
5.51
US$314,533 		57,084 5.51 US$314,533
2024-11-15 2024-11-15 PrS Proposed sale
DHILLON PUNIT

Officer; Director

Executive Director
100,693
5.51
US$554,818 		100,693 5.51 US$554,818
2024-11-15 2024-11-15 PrS Proposed sale
Diep Tuan Tu

Officer

Officer
22,877
5.51
US$126,052 		22,877 5.51 US$126,052
2024-11-15 2024-11-15 PrS Proposed sale
Grayson Paul A.

Director

Non-Executive Director
86,804
5.51
US$478,290 		86,804 5.51 US$478,290
2024-09-13 2024-09-13 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
79 -0.1%
6.06
US$479 		79 -0.1% 6.06 US$479
2024-09-13 2024-09-13 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
2,000 -0.1%
6.06
US$12,120 		2,000 -0.1% 6.06 US$12,120
2024-09-13 2024-09-13 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
11,758 -0.1%
6.06
US$71,253 		11,758 -0.1% 6.06 US$71,253
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
79 -0.1%
6.06
US$479 		79 -0.1% 6.06 US$479
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
2,000 -0.1%
6.06
US$12,120 		2,000 -0.1% 6.06 US$12,120
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
11,758 -0.1%
6.06
US$71,253 		11,758 -0.1% 6.06 US$71,253
2024-09-13 2024-09-11 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
1,440 -2.1%
6.60
US$9,504 		1,440 -2.1% 6.60 US$9,504
2024-09-13 2024-09-11 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
36,504 -2.1%
6.60
US$240,926 		36,504 -2.1% 6.60 US$240,926
2024-09-13 2024-09-11 S Sale
1.5
Schwab Andrew J.
Non-Executive Director Large shareholder
214,556 -2.6%
6.60
US$1,416,070 		214,556 -2.6% 6.60 US$1,416,070
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
1,440 -2.1%
6.60
US$9,504 		1,440 -2.1% 6.60 US$9,504
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
36,504 -2.1%
6.60
US$240,926 		36,504 -2.1% 6.60 US$240,926
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
214,556 -2.6%
6.60
US$1,416,070 		214,556 -2.6% 6.60 US$1,416,070
2024-03-15 2024-03-13 B Purchase
5AM Partners VII, LLC
Large shareholder
450,000 +5.7%
10.00
US$4,500,000 		450,000 +5.7% 10.00 US$4,500,000
2024-02-02 2024-01-31 B Purchase
5AM Partners VII, LLC
Large shareholder
5,206,074 +190.2%
2.31
US$12,026,031 		5,206,074 +190.2% 2.31 US$12,026,031
2023-08-29 2023-08-29 B Purchase
DHILLON PUNIT

Chief Executive Officer

Executive Director
881,000 +2.2%
0.02
US$16,475 		881,000 +2.2% 0.02 US$16,475
2018-02-21 2018-02-16 B Purchase Emerald Health Sciences Inc. Large shareholder
15,000,000
0.00
US$0 		15,000,000 0.00 US$0
2015-04-10 2015-04-10 S Sale Ladin Brian D Large shareholder
11,830 -4.5%
4.93
US$58,310 		11,830 -4.5% 4.93 US$58,310
2015-04-10 2015-04-08 S Sale Ladin Brian D Large shareholder
15,800 -5.7%
4.79
US$75,682 		15,800 -5.7% 4.79 US$75,682
2015-04-10 2015-04-08 S Sale Ladin Brian D Large shareholder
23,000 -7.7%
4.69
US$107,893 		23,000 -7.7% 4.69 US$107,893
Explore more

More insider trading research around Skye Bioscience, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America